Klor-con Tablet, Film Coated, Extended Release
Product Images NDC 0245-5315

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Klor-con (NDC 0245-5315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Klor-Con 8 is a medication that contains 600 mg of Potassium Chloride per extended-release tablet. It is used to treat or prevent certain types of low potassium levels in the blood. Dosage and usage instructions can be found in the package insert. Dosage must be adjusted according to individual needs. The tablets should be stored at room temperature, away from children, in a tightly closed container. Upsher-Smith Laboratories, LLC manufactures Klor-Con 8.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Each extended-release tablet contains: Potassium chloride, USP 750 mg (equivalent to potassium 10 mEq) with Klor-con 10 as the usual dosage. Dosage must be adjusted to the individual needs for each patient. It must be stored in a tight container with a child-resistant closure at a temperature between 20°C to 25°C (68°F to 77°F) and excursions permitted to 15° to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. This medication is manufactured by Upsher-Smith Laboratories LLC and is available only under Rx. Kior-Con is a registered trademark of Upsher-Smith Laboratories LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.